Encouraging Trial Data Sends Moderna Stock Soaring

Options bulls have taken a liking to in MRNA of late

Digital Content Manager
Dec 13, 2022 at 2:18 PM
facebook twitter linkedin

Moderna Inc (NASDAQ:MRNA) is up 23.6% at $204.04 at last check, after a mid-stage trial showed the combination of its experimental melanoma vaccine and Merck's (MRK) immunotherapy Keytruda lowered the risk of skin cancer's recurrence or death by 44%. In response, SVB Securities raised the stock's price target to $102 from $101.

Options are running red-hot today, with 103,000 calls and 64,000 puts traded so far, or five times the volume that's typically seen at this point. Most popular is the January 2023 220-strike call, followed by the 200-strike call in that series, with positions being opened at both.

This appetite for calls has been the norm lately. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the equity's 10-day call/put volume ratio of 3.47 sits higher than 99% of readings from the past year. Echoing this, MRNA's Schaeffer's put/call open interest ratio (SOIR) ranks higher than only 4% of annual readings, meaning short-term traders have rarely been more call-biased.  

The security is trading at its highest level since January, and burst through a ceiling at the $190 level earlier, after yesterday slipping below a recent floor at the $170 region. The shares are also eyeing their best day since March 2020, though year-over-year MRNA is still down 25.2%. 

 MRNA 1213 


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners